leon-nanodrugs raises EUR 18.5M in series A

leon-nanodrugs GmbH (Munich, Germany) raised EUR 18.5 million ($20.5 million) in the first close of a planned EUR 21.5 million ($23.8 million) series A round led by new investor TVM Capital Life Science. New investors Signet Healthcare Partners; LifeCare Partners; CD-Venture; Albany Private Equity Holding; and an undisclosed German family office also participated. leon-nanodrugs expects to receive the remaining EUR 3 million ($3.3 million) this year from an undisclosed Chinese company.

leon-nanodrugs uses nanotechnology to develop oral and parenteral formulations of small molecule and protein drug candidates with improved bioavailability, solubility and dissolution rates. ...